Duration and clinical outcomes of dual antiplatelet therapy following percutaneous coronary intervention for acute coronary syndrome: A multicentre “real-world practice” registry-based study

Duration and clinical outcomes of dual antiplatelet therapy following percutaneous coronary intervention for acute coronary syndrome: A multicentre “real-world practice” registry-based study

BackgroundThe optimal duration of dual antiplatelet therapy (DAPT) ought to be determined taking into account individual ischaemic or bleeding events risks. To date, studies have provided inconclusive evidence on the effects of prolonged DAPT. We sought to evaluate the long-term outcomes of this str...

Full description

Bibliographic Details
Main Authors: Carlos E. Vergara-Uzcategui, Víctor H. Moreno, Breda Hennessey, Rafael Sánchez-del-Hoyo, José H. Donis, Jorgelys Gonzalez-Rojas, Pablo Salinas, Luis Nombela-Franco, Nieves Gonzalo, Pilar Jimenez-Quevedo, Hernán Mejia-Renteria, Javier Escaned, Antonio Fernández Ortiz, Carlos Macaya Miguel, Iván J. Núñez-Gil
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
dual antiplatelet therapy
duration
outcomes
acute coronary syndrome
percutaneous coronary intervention
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1158466/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1158466/full

Similar Items